
### [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874)
**Label:** acute myeloid leukemia

**Subclasses:** [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), 

**Corr. equiv. classes:** [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [Orphanet:518](http://www.orpha.net/ORDO/Orphanet_518), [OMIM:133180](http://purl.obolibrary.org/obo/OMIM_133180), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [Orphanet:318](http://www.orpha.net/ORDO/Orphanet_318), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 33.50%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 32.37%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 32.37%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 32.37%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 32.37%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 32.37%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 31.86%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 30.56%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 26.55%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 22.71%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 18.31%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) 18.31%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 16.82%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 16.62%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 16.06%


